From the Independent Investment Research report (May 2017) under the investors link on the company website:-
While the ability to sensitize cancers to radiation would be a significant breakthrough, the ability to create an abscopal response on a regular basis would be a game changer in the treatment of cancer.
Just wanted to put your mind at ease RBx with regards to your closing assertion - exciting times ahead.
Some enlightened contributor might have have challenged this on the grounds that it was unsubstantiated information.
So as it turns out, you're not on thin ice after all.
Rest easy.
NOX Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held
(20min delay)